Sunshine Guojian Pharmaceutical (shanghai) Co., Ltd.

This study is testing whether an experimental drug called 608 can reduce disease activity and improve symptoms in adults with active ankylosing spondylitis, a painful inflammatory spinal condition. It will compare 608 against a placebo in 500 participants over 60 weeks to see if …

This study is testing an investigational drug called 611 to see if it can reduce the frequency of serious flare-ups and improve lung function in Chinese adults with moderate-to-severe COPD. About 594 participants who are already on standard COPD medications will receive either th…

This study is testing whether a new drug called 610 can reduce serious asthma attacks in Chinese adults with severe asthma. About 480 participants will receive either the drug or a placebo for one year to see if it lowers the number of attacks requiring emergency care. The main g…

This study is testing an experimental drug called 611 for teenagers with moderate-to-severe atopic dermatitis (eczema). It aims to see if the drug, given as an injection, can significantly clear skin and reduce itching compared to a placebo. The trial will involve 180 Chinese ado…

This study is testing an experimental antibody called SSGJ-626 for people with systemic lupus erythematosus (SLE), a chronic autoimmune disease. Researchers will compare SSGJ-626 plus standard care against placebo plus standard care in 198 adults with active lupus symptoms. The g…